These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38555664)

  • 1. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E).
    Higgins JPT; Morgan RL; Rooney AA; Taylor KW; Thayer KA; Silva RA; Lemeris C; Akl EA; Bateson TF; Berkman ND; Glenn BS; Hróbjartsson A; LaKind JS; McAleenan A; Meerpohl JJ; Nachman RM; Obbagy JE; O'Connor A; Radke EG; Savović J; Schünemann HJ; Shea B; Tilling K; Verbeek J; Viswanathan M; Sterne JAC
    Environ Int; 2024 Apr; 186():108602. PubMed ID: 38555664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures.
    Bero L; Chartres N; Diong J; Fabbri A; Ghersi D; Lam J; Lau A; McDonald S; Mintzes B; Sutton P; Turton JL; Woodruff TJ
    Syst Rev; 2018 Dec; 7(1):242. PubMed ID: 30577874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Introduction of a tool to assess Risk of Bias in Non-randomized Studies-of Environmental Exposure (ROBINS-E)].
    Wang WW; Zhou QX; Ma L; Feng SH; Yang ZR; Sun F; Zhan S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jan; 43(1):98-104. PubMed ID: 35130659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the ROBINS-I tool to natural experiments: an example from public health.
    Thomson H; Craig P; Hilton-Boon M; Campbell M; Katikireddi SV
    Syst Rev; 2018 Jan; 7(1):15. PubMed ID: 29368630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.
    Schünemann HJ; Cuello C; Akl EA; Mustafa RA; Meerpohl JJ; Thayer K; Morgan RL; Gartlehner G; Kunz R; Katikireddi SV; Sterne J; Higgins JP; Guyatt G;
    J Clin Epidemiol; 2019 Jul; 111():105-114. PubMed ID: 29432858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Series of risk of bias assessment (5): Risk Of Bias In Non-randomized Studies-of Interventions (ROBINS-I)].
    Sun F; Gao L; Yang ZR; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Mar; 39(3):374-381. PubMed ID: 29609257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RoB-SPEO: A tool for assessing risk of bias in studies estimating the prevalence of exposure to occupational risk factors from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
    Pega F; Norris SL; Backes C; Bero LA; Descatha A; Gagliardi D; Godderis L; Loney T; Modenese A; Morgan RL; Pachito D; Paulo MBS; Scheepers PTJ; Schlünssen V; Sgargi D; Silbergeld EK; Sørensen K; Sutton P; Tenkate T; Torreão Corrêa da Silva D; Ujita Y; van Deventer E; Woodruff TJ; Mandrioli D
    Environ Int; 2020 Feb; 135():105039. PubMed ID: 31864023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
    Anglemyer A; Horvath HT; Bero L
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochrane's risk of bias tool for non-randomized studies (ROBINS-I) is frequently misapplied: A methodological systematic review.
    Igelström E; Campbell M; Craig P; Katikireddi SV
    J Clin Epidemiol; 2021 Dec; 140():22-32. PubMed ID: 34437948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety interventions for the prevention of accidents at work: A systematic review.
    Dyreborg J; Lipscomb HJ; Nielsen K; Törner M; Rasmussen K; Frydendall KB; Bay H; Gensby U; Bengtsen E; Guldenmund F; Kines P
    Campbell Syst Rev; 2022 Jun; 18(2):e1234. PubMed ID: 36911341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the risk of bias in non-randomized studies of interventions (ROBINS-I) and the 'target experiment' concept in studies of exposures: Rationale and preliminary instrument development.
    Morgan RL; Thayer KA; Santesso N; Holloway AC; Blain R; Eftim SE; Goldstone AE; Ross P; Guyatt G; Schünemann HJ
    Environ Int; 2018 Nov; 120():382-387. PubMed ID: 30125855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Risk Factor Collaborators
    Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Introduction of a tool to assess Risk of Bias in Non-randomized Studies-of Exposure (2022)].
    Sun YH; Wang XX; Pei MY; Ma XJ; Ying YY; Zhan SY; Li N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Sep; 44(9):1454-1461. PubMed ID: 37743281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study.
    Toews I; Anglemyer A; Nyirenda JL; Alsaid D; Balduzzi S; Grummich K; Schwingshackl L; Bero L
    Cochrane Database Syst Rev; 2024 Jan; 1(1):MR000034. PubMed ID: 38174786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common challenges and suggestions for risk of bias tool development: a systematic review of methodological studies.
    Tomlinson E; Cooper C; Davenport C; Rutjes AWS; Leeflang M; Mallett S; Whiting P
    J Clin Epidemiol; 2024 Jul; 171():111370. PubMed ID: 38670243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.